Type 2 Diabetes Clinical Trials
Type 2 Diabetes Trials at a Glance
500 actively recruiting trials for type 2 diabetes are listed on ClinicalTrialsFinder across 6 cities in 63 countries. The largest study group is Not Applicable with 228 trials, with the heaviest enrollment activity in San Antonio, Dallas, and Houston. Lead sponsors running type 2 diabetes studies include The University of Texas Health Science Center at San Antonio, Eli Lilly and Company, and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd..
Browse type 2 diabetes trials by phase
Top cities for type 2 diabetes trials
Understanding Type 2 Diabetes Clinical Trials
Semaglutide (Ozempic, Wegovy), which emerged from clinical trials as a GLP-1 receptor agonist, has not only improved blood sugar control but also demonstrated significant cardiovascular and weight-loss benefits that have reshaped how type 2 diabetes is managed. SGLT2 inhibitors like empagliflozin (Jardiance), also validated through landmark trials, have proven to protect the heart and kidneys in addition to lowering glucose. Clinical trials continue to push the boundaries of diabetes care, testing next-generation therapies that aim to achieve remission, protect organs, and reduce the daily burden of managing this chronic condition.
Why Consider a Clinical Trial?
Frequently Asked Questions
Common questions about Type 2 Diabetes clinical trials
It depends on the trial. Some studies allow you to continue your current medications and add the investigational treatment on top. Others may require you to stop or adjust certain medications to accurately assess the new therapy's effect. The study team will explain medication requirements during screening and ensure any changes are made safely.
The investigational treatment and research-related tests are typically covered by the trial sponsor at no cost to you. Routine care costs are usually billed to your insurance. Some trials offer stipends or reimbursement for travel and parking. Ask the study coordinator about financial details before enrolling.
Visit frequency varies by trial but is commonly every 4 to 12 weeks during active treatment. Some visits involve blood draws and physical exams, while others may be shorter check-ins. Many modern diabetes trials incorporate telehealth options to reduce the number of in-person visits required.
Many diabetes trials accept participants with common comorbidities, and some specifically study diabetes treatments in patients with cardiovascular or kidney disease. However, each trial has its own eligibility criteria. Having additional health conditions does not automatically disqualify you, and some trials are designed specifically for these populations.
When the trial ends, your study team will work with your regular doctor to transition you back to standard care. If the investigational treatment was effective, you may be eligible for an extension study that provides continued access. Your study team will ensure you have an appropriate treatment plan in place before discharge.
Showing 1–20 of 500 trials